Hua Zou

403 total citations
13 papers, 298 citations indexed

About

Hua Zou is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Hua Zou has authored 13 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Medicine, 7 papers in Pharmacology and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in Hua Zou's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antibiotic Use and Resistance (5 papers). Hua Zou is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Antibiotic Use and Resistance (5 papers). Hua Zou collaborates with scholars based in China and Hong Kong. Hua Zou's co-authors include Xiaojiong Jia, Shifeng Huang, Qibo Sun, Shangguang Wang, Zibin Zheng, Hang Liu, Qiuxia Lin, Siqiang Niu, Hang Liu and Shuang Li and has published in prestigious journals such as Frontiers in Microbiology, Frontiers in Pharmacology and Frontiers in Oncology.

In The Last Decade

Hua Zou

13 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Zou China 10 183 79 72 66 50 13 298
Fasahath Husain United States 11 177 1.0× 47 0.6× 35 0.5× 7 0.1× 4 0.1× 15 515
Myungseo Park South Korea 11 92 0.5× 54 0.7× 16 0.2× 105 1.6× 3 0.1× 41 396
Michael Meier Germany 11 44 0.2× 12 0.2× 7 0.1× 60 0.9× 7 0.1× 38 379
Satyam Prakash Nepal 10 26 0.1× 16 0.2× 16 0.2× 11 0.2× 19 0.4× 33 279
Will Rowe United Kingdom 14 156 0.9× 85 1.1× 17 0.2× 3 0.0× 27 0.5× 15 544
R. Srinivasa Rao India 9 100 0.5× 66 0.8× 12 0.2× 2 0.0× 20 0.4× 12 364
Karel Břinda United States 9 177 1.0× 46 0.6× 9 0.1× 3 0.0× 24 0.5× 19 469
Qiqiang Liang China 11 157 0.9× 36 0.5× 62 0.9× 47 0.9× 18 310
Wenjuan Liang China 11 41 0.2× 27 0.3× 12 0.2× 7 0.1× 6 0.1× 37 365
Michelle M. Li United States 6 56 0.3× 28 0.4× 6 0.1× 5 0.1× 7 0.1× 12 360

Countries citing papers authored by Hua Zou

Since Specialization
Citations

This map shows the geographic impact of Hua Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Zou more than expected).

Fields of papers citing papers by Hua Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Zou. The network helps show where Hua Zou may publish in the future.

Co-authorship network of co-authors of Hua Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Zou. A scholar is included among the top collaborators of Hua Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Zou. Hua Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zou, Hua, Xiaojiong Jia, He Xiao, et al.. (2021). Emerging Threat of Multidrug Resistant Pathogens From Neonatal Sepsis. Frontiers in Cellular and Infection Microbiology. 11. 694093–694093. 24 indexed citations
2.
Jia, Xiaojiong, Si Cheng, Hua Zou, et al.. (2021). Elevated Red Blood Cell Distribution Width as a Poor Prognostic Factor in Patients With Hematopoietic Stem Cell Transplantation. Frontiers in Oncology. 10. 565265–565265. 2 indexed citations
3.
Lin, Qiuxia, et al.. (2021). Clinical and Microbiological Characterization of Carbapenem-Resistant Enterobacteriales: A Prospective Cohort Study. Frontiers in Pharmacology. 12. 716324–716324. 10 indexed citations
4.
Lin, Qiuxia, et al.. (2021). Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro. BMC Microbiology. 21(1). 60–60. 22 indexed citations
6.
Jia, Xiaojiong, et al.. (2020). Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. International Journal of Antimicrobial Agents. 55(3). 105832–105832. 17 indexed citations
8.
Liu, Hang, Xiaojiong Jia, Hua Zou, et al.. (2019). Detection and characterization of tigecycline heteroresistance in E. cloacae : clinical and microbiological findings. Emerging Microbes & Infections. 8(1). 564–574. 28 indexed citations
9.
Zou, Hua, et al.. (2019). Elevated serum CXCL10 in patients with Clostridium difficile infection are associated with disease severity. International Immunopharmacology. 72. 92–97. 8 indexed citations
12.
Jia, Xiaojiong, et al.. (2018). Carbapenem-resistant and cephalosporin-susceptible <em>Pseudomonas aeruginosa</em>: a notable phenotype in patients with bacteremia. Infection and Drug Resistance. Volume 11. 1225–1235. 26 indexed citations
13.
Wang, Shangguang, et al.. (2011). Cloud model for service selection. 666–671. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026